Litcius/Paper detail

Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial

Claire Gallois, Jean‐François Emile, Stéfano Kim, Carole Montérymard, Marine Gilabert, Jérémie Bez, Astrid Lièvre, Laëtitia Dahan, Pierre Laurent‐Puig, Laurent Mineur, Romain Coriat, Jean-Louis Legoux, Vincent Hautefeuille, Jean–Marc Phelip, Thierry Lecomte, Harry Sokol, Claude Capron, Violaine Randrian, Côme Lepage, Nicolas Loménie, Camille Kurtz, Julien Taı̈eb, David Tougeron

2021Digestive and Liver Disease15 citationsDOIOpen Access PDF

Topics & Concepts

PembrolizumabBevacizumabMedicineOxaliplatinColorectal cancerClinical endpointOncologyMicrosatellite instabilityInternal medicineChemotherapyCancerImmunotherapyRandomized controlled trialBiologyMicrosatelliteAlleleGeneBiochemistryCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer